See the potential ROI of your corporate weight management strategy.
Explore how our corporate weight loss program could impact your organization’s healthcare costs through evidence-based behavior change and GLP-1 medication management.
Enter your business information to access our ROI calculator and generate a three-year projection based on your eligible population, Wondr Health outcomes, and published industry benchmarks.
Three-year financial projection
Estimate savings, investment, and ROI over time.
Population-based estimates
Explore projections based on your eligible population.
Flexible clinical pathways
Account for behavior change and clinical access to GLP-1 medications.
Corporate weight management programs delivering measurable business impact
ROI in the plan year
Built for the people shaping workforce healthcare outcomes.
Give employees a weight management solution they actually use, while reducing obesity-related costs and supporting healthier, more productive teams.
• Improve employee health outcomes through sustainable behavior change
• Support responsible GLP-1 utilization with flexible funding options
• Reduce chronic disease risk and obesity-related healthcare costs
• Drive measurable ROI with proven savings and engagement
Support employer clients in addressing obesity-related risk and cost with a flexible, evidence-based solution that improves employee health outcomes and strengthens the financial performance of their benefits strategy.
• Bring clients a modern approach to weight management and GLP-1s
• Demonstrate measurable value through ROI and cost-savings insights
• Support smarter benefits strategies with configurable funding options
• Differentiate your recommendations with proven health outcomes
Deliver whole-person obesity care that improves member outcomes, strengthens retention, and helps manage rising healthcare and GLP-1 costs.
• Improve member engagement and long-term health outcomes
• Reduce reliance on high-cost interventions through preventive care
• Optimize GLP-1 and anti-obesity medication strategies
• Scale across commercial, self-funded, and Medicare populations